Erigotheel vials
Drug name: Erigotheel
Active Ingredients:
- Erythraea centaurium
- Origanum vulgare
Therapeutic actions:
Bitter substances of the medication increase the excitability of the sympathetic nerve and suppress the activity of the vagus nerve. Erigotheel regulates the secretory functions of the stomach mucous lining and duodenum. Erigotheel stimulates the production of hydrochloric acid in the stomach.Indications:
- Erigotheel is indicated in the complex treatment of stomach and duodenal ulcers
Contraindications and cautions:
- Erigotheel should not be taken in known hypersensitivity or allergy to any of the medication ingredients
- Talk with your doctor if you are pregnant or breastfeeding
Adverse effects: There are possible side effects associated with this medicine that can affect individuals in different ways. If a side effect is stated here, that does not necessarily mean the fact that all people using Erigotheel will experience it or any other.
- In rare cases Erigotheel may cause dermatological reactions and dyspepsia
The side effects listed above may not include all of the side effects reported by the drug's manufacturer.
For more information about any other possible risks associated with Erigotheel, please read the information provided with Erigotheel or consult your doctor or pharmacist.Interactions: It is important to tell your doctor or pharmacist what medicines you are already taking, including those bought without a prescription and herbal medicines, before you start treatment with Erigotheel. Similarly, check with your doctor or pharmacist before taking any new medication while taking this one, to ensure that the combination is safe. Especially pay attention to:
- Other homeopathic preparations
- Stomach preparations
Additional Information: DO NOT SHARE Erigotheel with others. DO NOT USE THIS MEDICINE for other health conditions. KEEP THIS PRODUCT, as well as syringes and needles, if needed during treatment, out of the reach of children. Do not reuse needles, syringes, or other materials.
